Reports suggest J&J's Actelion takeover is edging closer

6 January 2017
mergers-acquisitions-big

The latest on the takeover talks between US health care giant Johnson & Johnson (NYSE: JNJ) and its target Actelion (SIX: ATLN) is that Switzerland’s takeover board has been asked about the viability of a complex deal.

This update has been reported by Swiss newspaper Tages-Anzeiger, which does not quote sources but suggests that the two companies have approached the board, which determines whether a deal meets legal requirements.

The two companies reportedly asked about a proposal under which J&J would acquire Actelion, while separating its commercialized portfolio from its research and development (R&D) assets, a deal structure first reported by the Reuters news agency last week.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology